Monday, November 07, 2016 11:50:45 PM
Under the EBITDA calculations and above ratios, it's a trailing 12-month calculation against the net income of certain pro forma adjustments that account for the impact of material acquisitions for divestitures, adjustments for interest or taxes or depreciation and amortization, and net income attributable to noncontrolling interest, stock compensation, restructuring costs, and the financial impact of other non-cash or nonrecurring items during a 12-month period.
For the 12-month period ending September 30, 2016, the secured net leverage ratio of financial covenant other than the ratios of secured debt is defined to less than 4.25 to 1. And for the 12-month period ending September 30, the interest ratio financial covenant in the credit facility limited to ratio of consolidated EBITDA or consolidated interest to greater than or equal to 2.0.
The Company was in compliance with all such covenants as September 30, 2016, with a secured net leverage ratio of 3.95 and an interest rate coverage of 2.55. Our interest rate cushion on our secured leverage ratio is about 7% and our EBITDA cushion on interest coverage is about 27%.
Recent CYH News
- Community Health Systems, Inc. Announces First Quarter Ended March 31, 2024 Results • Business Wire • 04/24/2024 08:15:00 PM
- Community Health Systems Announces Definitive Agreement to Sell Cleveland, Tennessee, Hospital to Hamilton Health Care System • Business Wire • 04/18/2024 08:15:00 PM
- Community Health Systems to Webcast First Quarter 2024 Conference Call • Business Wire • 04/10/2024 03:00:00 PM
- Community Health Systems Addresses Health Disparities through Doctors’ Day Donations and Second Annual Jars of Love Peanut Butter Drive • Business Wire • 03/28/2024 01:00:00 PM
- Community Health Systems Partners With Mark Cuban Cost Plus Drug Company to Address the Rising Cost of Drugs and Potential Drug Shortages • Business Wire • 03/07/2024 02:00:00 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 03/04/2024 11:07:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:59:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:58:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:57:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:57:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:56:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:56:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:55:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:55:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:54:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:54:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:53:31 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:52:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:51:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:51:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:50:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:50:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:49:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:49:09 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM